samedi 1 octobre 2011

Press review (October 1, 2011) – Revue de presse (1er octobre 2011)




Fighting Cervical Cancer With Vinegar and Ingenuity
Nurses using the new procedure, developed by experts at the Johns Hopkins medical school in the 1990s and endorsed last year by the World Health Organization, brush vinegar on a woman’s cervix. It makes precancerous spots turn white. They can then be immediately frozen off with a metal probe cooled by a tank of carbon dioxide, available from any Coca-Cola bottling plant..
By Donald G. McNeil Jr.In The New York Times

Breast cancer treatment change could save time, money
Women facing radiation treatments after breast cancer surgery could complete the therapy in half the time, saving patients time and money and returning them more quickly to normal life if a major national study delivers on expectations.
By Patricia Anstett. In USAToday

“50/50”: Half-Life
Identifying the cellular origins of breast cancer might lead to earlier diagnosis and more efficient management of the disease. New research led by Charlotte Kuperwasser of Tufts University School of Medicine (TUSM) has determined that common forms of breast cancer originate from breast cells known as luminal epithelial cells while rarer forms of breast cancer, such as metaplastic carcinomas, originate from basal epithelial cell types. The study was published online ahead of print this week in PNAS Early Edition as part of its breast cancer special feature.
By Richard Brody. In The New Yorker (blog)

Study Says Big Tobacco Covered Up Info on Cancer Risk
A new study claims that tobacco companies knew for years that cigarette smoke contained dangerous and potentially deadly radioactivity but purposefully didn't let the public know.
U.S. News & World Report

Diabetes again linked to colon cancer risk: study
People with diabetes have a somewhat increased risk of colon cancer, an international study said -- but the reasons for the connection, and what should be done about it, remain unclear.
By Elaine Lies. Reuters

Breast cancer drug could add five months
A new breast cancer drug could hold back the growth of cancer by five months while reducing dangerous side effects, early trial results suggest.
By Nick Collins. In Telegraph.co.uk

Chemotherapy Safe to Give During Pregnancy
A cancer diagnosis can be devastating, but is even more traumatic when the patient is pregnant. A new study offers some reassurance to pregnant patients and their physicians.
By Roxanne Nelson. Medscape

Cancer Care's “Culture of Excess”‎
You probably didn’t need an expert panel of researchers to tell you that the cost of treating cancer is spiraling out of control. But one did, and what that panel has to say is eye-opening, even when you’ve heard it all before.
By Jessica Wapner. In PLoS Blogs (blog)

Cancer drug too expensive for NHS
A chemotherapy drug that extends the lives of men with advanced prostate cancer is too expensive for use on the NHS, according to draft guidance. The National Institute for Health and Clinical Excellence (Nice) said cabazitaxel (Jevtana), in combination with prednisone or prednisolone was not cost-effective as a second line treatment after hormone therapy.
By Jane Kirby. In The Independant

ECCO-ESMO: Hypercalcemia of Cancer Stalled By Antibody
Hypercalcemia of malignancy occurred half as often in cancer patients treated with denosumab (Xgeva) than in those given zoledronic acid (Zometa), analysis of data from two large clinical trials showed.
By Charles Bankhead. MedPage Today

Cancer du sein : Octobre rose lancé sur fond de polémique sur le dépistage‎
L'édition 2011 d'Octobre rose, mois de mobilisation en faveur du dépistage du cancer du sein, a été lancée mercredi, sur fond de polémique sur le risque de surdiagnostic, alors que le programme national de dépistage marque le pas.
Par Annie HAUTEFEUILLE. AFP

50/50: guérison par la dérision
Il est important, il est même urgent, de rire dans la vie. L’humour n’est pas qu’un art, qu’une industrie; il s’agit, répète-t-on souvent, d’une véritable thérapie. 50/50, comédie dramatique ou drame comique, participe de cette belle idée, fort répandue, qu’il vaut toujours mieux en rire qu’en pleurer. Et réussit, parfois à moitié, le pari d’amuser et de divertir avec un sujet plutôt rébarbatif: le cancer.
Par Aleksi K. Lepage. Dans Cyberpresse

Les hommes ont plus de lésions au côlon que les femmes, selon une étude
Les hommes ont davantage de lésions au côlon que les femmes à tout âge ce qui laisse penser qu'ils présentent un risque accru de cancer colorectal, selon une étude effectuée en Autriche publiée mardi aux Etats-Unis.
AFP

L'inhibition de protéines ralentirait les métastases osseuses
Des chercheurs en France ont découvert comment les métastases osseuses peuvent être retardées. Lors du récent congrès européen multidisciplinaire sur le cancer tenu cette année à Stockholm, en Suède, le professeur Stéphane Oudard, du département d'oncologie à l'hôpital George Pompidou en France, faisait remarquer que l'inhibition d'une protéine impliquée dans le métabolisme osseux était essentielle au retardement de métastases osseuse, une occurrence fréquente chez les hommes chez qui une forme particulière de cancer de la prostate est diagnostiquée.
CORDIS Nouvelles



Aucun commentaire:

Enregistrer un commentaire